Prosecution Insights
Last updated: November 04, 2026
Application No. 18/561,340

GLASS COMPONENT

Final Rejection §103
Filed
Nov 16, 2023
Priority
May 20, 2021 — JP 2021-085697 +1 more
Examiner
BERRO, ADAM JOSEPH
Art Unit
1765
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Sakamoto Yakuhin Kogyo Co. Ltd.
OA Round
2 (Final)
52%
Grant Probability
Moderate
3-4
OA Rounds
6m
Est. Remaining
98%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allowance Rate
31 granted / 59 resolved
-12.5% vs TC avg
Strong +46% interview lift
Without
With
+45.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
43 currently pending
Career history
128
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
63.1%
+23.1% vs TC avg
§102
9.0%
-31.0% vs TC avg
§112
18.7%
-21.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 59 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Status of Claims The examiner acknowledges the amendment to claim 1 and the cancellation of claims 2-10. Claim 1 is pending. Claim Interpretation Claim 1 is interpreted as a product-by-process claim based upon the language of “a glass formed by curing a glass component…obtained by reacting” which is directed towards the cured product and not the components prior to curing. As such, only the product can be used to determine the patentability. See MPEP 2113.I. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claim 1 is rejected under 35 U.S.C. 103 as being unpatentable over Miyanaga (EP 1489128). Miyanaga teaches a silicon containing compound that can be used as a glazing, sealant, or protective material for optical fibers (Paragraph 93) where these uses would imply a curing step is conducted. Miyanaga teaches that the composition contains a polyglycerol derivative which contains 2 to 100 glycerol units (Paragraph 22), which overlaps with the range of the instant claim. It would have been obvious prior to the effective filing date of the instant application to have selected the overlapping portion of the ranges because the selection of overlapping portion of ranges has been held to be a prima facie case of obviousness. See MPEP 2144.05.I. Miyanaga further teaches that the composition contains linking groups (Paragraph 24) comprised of alkyleneoxy units of 1 to 4 carbons (Paragraph 24) and where the number of repeat units is up to 30 (Paragraph 24). Miyanaga also teaches that the alkylene oxide groups should be present in a ratio of 0.5 mole per mole of glycerol or less (Paragraph 50), meeting the requirement of less than 130 repeat units. Miyanaga teaches that the composition contains a silicone of the following structure from page 7: PNG media_image1.png 116 414 media_image1.png Greyscale where the R groups can be the alkyleneoxy linking groups which attach the polyglycerol component (Paragraph 41) as well as alkoxy groups (Paragraph 42), alkenyl groups such as vinyl (Paragraph 42), and groups with the following structure on page 9: PNG media_image2.png 100 328 media_image2.png Greyscale which meets the requirement of a reactive functional group. While Miyanaga does not teach the components specified in the instant claim, because the claim is structured as a product-by-process claim, because Miyanaga teaches a compound that would result in a cured product meeting the requirements of the instant claims, the product reads upon the claim. Response to Arguments Applicant’s arguments with respect to claim 1 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Stanjek teaches a silane-crosslinkable coating composition which is comprised of glycerol or derivatives in combination with polyether polyols and isocyanatosilanes that is curable. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ADAM J BERRO whose telephone number is (703)756-1283. The examiner can normally be reached M-F 8:30-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /A.J.B./Examiner, Art Unit 1765 /JOHN M COONEY/Primary Examiner, Art Unit 1765
Read full office action

Prosecution Timeline

Nov 16, 2023
Application Filed
May 15, 2026
Non-Final Rejection mailed — §103
Aug 11, 2026
Response Filed
Oct 20, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12780979
METHODS OF SYNTHESIZING MULTI-HYDROGEN BONDING OLIGOMERS
4y 1m to grant Granted Nov 03, 2026
Patent 12767764
A METHOD OF PREPARING ALKYL FUNCTIONALIZED POLYSILOXANE
3y 7m to grant Granted Oct 20, 2026
Patent 12723156
POLYIMIDE RESIN COMPOSITION AND MOLDED BODY
3y 5m to grant Granted Sep 01, 2026
Patent 12703813
COMPOSITION FOR PREPARING A RELEASE COATING, RELEASE COATING COMPOSITION, AND RELATED METHODS
4y 1m to grant Granted Aug 11, 2026
Patent 12680002
UNDERFILL FILM FOR SEMICONDUCTOR PACKAGE AND METHOD FOR MANUFACTURING SEMICONDUCTOR PACKAGE USING SAME
4y 1m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
52%
Grant Probability
98%
With Interview (+45.8%)
3y 5m (~6m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 59 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month